PHYTOCHEMICALS
June 1, 2022- Stem cell therapy in perspective
- Adult Stem cell therapy in perspective
- Stem cell therapy for human neurodegenerative disorders–how to make it work
- Stable benefit of embryonic Stem cell therapy in myocardial infarction
- Stem–cell therapy for diabetes mellitus
- New prospects for human Stem–cell therapy in the nervous syStem
- Neural Stem cell therapy for neurological diseases: dreams and reality
- Stem cell therapy in a caprine model of osteoarthritis
- Stem cell therapy and gene transfer for regeneration
- Adult Stem cell therapy for the heart
- Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans
- Nonmyeloablative Stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of …
- Mesenchymal Stem cell therapy in joint disease
- The effect of neural embryonic Stem cell therapy in a rat model of cavernosal nerve injury
- Stem–cell therapy for amyotrophic lateral sclerosis
- Potential of hematopoietic Stem cell therapy in hepatology: a critical review
- Becoming immortal: Combining cloning and Stem–cell therapy
- 28. Embryonic and adult Stem cell therapy
- Dentin regeneration by dental pulp Stem cell therapy with recombinant human bone morphogenetic protein 2
- Stem cell and precursor cell therapy
- Stem cell therapy for ischemic heart disease
- Intervertebral disc cell therapy for regeneration: mesenchymal Stem cell implantation in rat intervertebral discs
- Stem cell therapy for ocular disorders
- Potential Stem cell therapy and application in neurotrauma
- Stem cell therapy of the liver—fusion or fiction?
- Stem cell therapy for diabetes: do we need to make beta cells?
- Stem cell therapy for myocardial repair: is it arrhythmogenic?
- Neural Stem cell therapy in the aging brain: pitfalls and possibilities
- Stem cell therapy for urinary incontinence
- Stem–cell therapy for renal diseases
- Stem cell therapy forcerebral palsy
- Genetically engineered Stem cell therapy for tissue regeneration
- Emerging neuroprotective strategies for Alzheimer’s disease: dietary restriction, telomerase activation, and Stem cell therapy
- Hematopoietic Stem cell therapy for type 1 diabetes: induction of tolerance and islet cell neogenesis
- In utero Stem cell therapy.
- Stem cell therapy for Parkinson’s disease: where do we stand?
- Stem cell therapy for the infarcted heart (“cellular cardiomyoplasty”)
- Monitoring Stem cell therapy in vivo using magnetodendrimers as a new class of cellular MR contrast agents
- Stem cell therapy for muscular dystrophy
- Stem cell therapy in ischemic heart disease
- Adult Stem cell therapy for heart failure
- Stem–cell therapy for myocardial diseases
- Stem cell therapy for the heart
- Stem cell therapy of cardiac disease: an update
- Applications of magnetic resonance imaging for cardiac Stem cell therapy
- The origin and development of the immune syStem with a view to Stem cell therapy
- Stem cell origin of cancer and differentiation therapy
- Novel approaches to allogeneic Stem cell therapy
- Autologous bone marrow-derived Stem cell therapy in combination with TMLR. A novel therapeutic option for endstage coronary heart disease: report on 2 cases.
- Immune ablation and Stem–cell therapy in autoimmune disease-Clinical experience
- Stem–cell therapy for amyotrophic lateral sclerosis
- Stem cell therapy for neurodegenerative diseases: the issue of transdifferentiation
- Hematopoietic Stem cell therapy of autoimmune diseases.
- Three-dimensional approach to Stem cell therapy
- Editorial Stem cell therapy in human ALS
- Stem cell therapy in utero
- Human embryonic Stem cell therapy
- Stem cell plasticity: the growing potential of cellular therapy
- Pancreatic islet and Stem cell transplantation: new strategies in cell therapy of diabetes mellitus.
- Cardiovascular disease: potential impact of Stem cell therapy
- From Stem cells to beta cells: new strategies in cell therapy of diabetes mellitus
- Additional Stem cell therapy for graft failure after allogeneic bone marrow transplantation
- Stem cell therapy for ALS: Hope and Reality A discussion paper from the Executive of the European ALS Consortium
- Allogeneic cell therapy for patients who relapse after autologous Stem cell transplantation
- Stem cell plasticity or fusion: two approaches to targeted cell therapy
- Augmentation of virus-specific immunity after hematopoietic Stem cell transplantation by adoptive T-cell therapy
- Stem cell therapy for myocardial infarction
- Stem cell therapy in acute myocardial infarction
- Stem cell therapy for neurological disease and injury.
- Correction of ADA-SCID by Stem cell gene therapy combined with nonmyeloablative conditioning
- Stem cell therapy for urinary incontinence and pelvic floor disorders: a novel approach
- Bone-marrow Stem cells as a source for cell therapy
- Stem–cell therapy: what dose should we use?
- Stem‐cell plasticity and therapy for injuries of the peripheral nervous syStem
- Public Stem cell banks: considerations of justice in Stem cell research and therapy
- Hematopoietic Stem cell compartment: acute and late effects of radiation therapy and chemotherapy
- Immune ablation and Stem–cell therapy in autoimmune disease: experimental basis for autologous Stem–cell transplantation
- Stem cells for cell therapy in Parkinson’s disease
- Dendritic-cell therapy after non-myeloablative Stem–cell transplantation for renal-cell carcinoma
- Nuclear transplantation, embryonic Stem cells and the potential for cell therapy
- Mylotarg™(gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received Stem cell transplantation
- cell therapy: Stem cell transplantation, gene therapy, and cellular immunotherapy
- Comparison of high-dose therapy and autologous Stem–cell transplantation with conventional therapy for Hodgkin’s disease induction failure: a case-control study
- Autologous Stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn’s disease: a new cell-based therapy
- Current status and perspectives of Stem cell therapy for the treatment of diabetes mellitus
- Neural Stem cells in the developing central nervous syStem: implications for cell therapy through transplantation
- Nuclear transplantation, embryonic Stem cells, and the potential for cell therapy
- Exogenously regulated Stem cell-mediated gene therapy for bone regeneration
- The potential for Stem cell therapy in cystic fibrosis.
- High-dose therapy with autologous Stem cell transplantation in patients with peripheral T cell lymphomas
- Neuroreplacement therapy and Stem cell biology under disease conditions
- Stem cell gene therapy for chronic renal failure
- In utero hematopoietic Stem cell therapy
- Embryonic Stem cell therapy in experimental stroke: host-dependent malignant transformation
- Adoptive cellular therapy for early cytomegalovirus infection after allogeneic Stem–cell transplantation with virus-specific T-cell lines
- Prostate Stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate
- Influenza infections after hematopoietic Stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy
- Music therapy for mood disturbance during hospitalization for autologous Stem cell transplantation: a randomized controlled trial
- The potential of marrow stromal cells in Stem cell therapy
- cell therapy using human embryonic Stem cells
- Impact on survival of high-dose therapy with autologous Stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population …
- High-dose therapy and autologous peripheral blood Stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential …
- High‐dose therapy with autologous haemopoietic Stem cell support for Waldenström’s macroglobulinaemia
- A new concept of Stem cell disorders and their new therapy
- … response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic Stem cell transplantation. Myeloma Subcommittee of the …
- Autologous peripheral hematopoietic Stem cell transplantation restores hematopoietic function following marrow ablative therapy
- Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous Stem cell transplantation for relapsed B cell lymphomas
- A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic Stem cell transplantation
- Paradigms of adult Stem cell therapy for type 1 diabetes in mice
- CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic Stem–cell transplantation
- … ablation and Stem–cell therapy in autoimmune disease Immunological reconstitution after high-dose immunosuppression and haematopoietic Stem–cell …
- Rituximab and ICE as second-line therapy before autologous Stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma
- Heal thyself: Potential applicability of Stem cell therapy in the management of heart disease
- Stem cell therapy for autoimmune disease: overview of concepts from the Snowbird 2002 tolerance and tissue regeneration meeting
- The graft-versus-tumor potential of allogeneic cell therapy: an update on donor leukocyte infusions and nonmyeloablative allogeneic Stem cell transplantation
- High-dose immunosuppressive therapy and autologous peripheral blood Stem cell transplantation for severe multiple sclerosis
- … impact of cytomegalovirus serostatus of donor and recipient before hematopoietic Stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy
- Innovative approaches of adoptive immune cell therapy in paediatric recipients of haematopoietic Stem cell transplantation
- Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic Stem cell transplantation: risk factors, correlation with DNA …
- Prognostic factors for survival and response after high‐dose therapy and autologous Stem cell transplantation in syStemic AL amyloidosis: a report on 21 patients
- Parainfluenza virus infections after hematopoietic Stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome
- High-dose therapy and autologous peripheral blood Stem cell transplantation for patients with lymphoma
- Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy
- 486: Stem cell therapy in Treatment of Urinary Incontinence: First Clinical Results
- Mesenchymal Stem–cell therapy in a regulated environment
- therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous Stem cell transplantation
- Stem cell therapy in scleroderma
- High-dose therapy and autologous blood Stem cell transplantation in POEMS syndrome
- First-line therapy with thalidomide and dexamethasone in preparation for autologous Stem cell transplantation for multiple myeloma
- Intensive therapy with peripheral Stem cell transplantation in 16 patients with mantle cell lymphoma
- Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic Stem cell transplantation: Presented in …
- Infectious complications after allogeneic Stem cell transplantation: epidemiology and interventional therapy strategies
- Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and Stem–cell rescue: results of the Chicago Pilot II Study
- Viral interleukin-10–engineered autologous hematopoietic Stem cell therapy: a novel gene therapy approach to prevent graft rejection
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the therapy of multiple myeloma: an evidence-based review
- Thoracic transplantation and Stem cell therapy
- High-dose therapy with Stem cell transplantation for mantle cell lymphoma: results and prognostic factors, a single center experience
- P75. Feasibility of Stem cell therapy for intervertebral disc degeneration
- Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic Stem cell transplantation: a phase …
- Imatinib mesylate therapy for relapse after allogeneic Stem cell transplantation for chronic myelogenous leukemia
- High-dose therapy and autologous Stem cell transplantation for multiple myeloma poorly responsive to initial therapy
- Prognostic factors for survival after high-dose therapy and autologous Stem cell transplantation for patients with relapsing Hodgkin’s disease: analysis of 280 patients …
- Should immunoglobulin therapy be used in allogeneic Stem–cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial
- Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood Stem cell support
- Relationship between spermatogonial Stem cell survival and testis function after cytotoxic therapy.
- High-dose melphalan, etoposide, total-body irradiation, and autologous Stem–cell reconstitution as consolidation therapy for high-risk Ewing’s sarcoma does not …
- High-dose therapy and autologous Stem–cell transplantation for adult patients with Hodgkin’s disease who do not enter remission after induction chemotherapy: results …
- The role of high-dose therapy and autologous hematopoietic Stem cell transplantation for mantle cell lymphoma
- Stem cell strategies for neuroreplacement therapy in Alzheimer’s disease
- Immune reconstitution to cytomegalovirus after allogeneic hematopoietic Stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation
- High-dose intravenous melphalan and autologous Stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of …
- Blood Stem cell transplantation as therapy for primary syStemic amyloidosis (AL)
- … dose therapy and autologous Stem–cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients …
- Endocrine complications of high‐dose therapy with Stem cell transplantation
- A human umbilical cord Stem cell rescue therapy in a murine model of toxic liver injury
- High-dose therapy and autologous haematopoietic Stem–cell transplantation for HIV-1-associated lymphoma
- Hematopoietic Stem cell transplantation: a new therapy for autoimmune disease
- Implications of long-term survival in acute Stem cell leukemia of childhood treated with composite cyclic therapy
- … and autologous peripheral-blood Stem–cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy
- Pluripotent Stem cells–model of embryonic development, tool for gene targeting, and basis of cell therapy
- Sequential chemotherapy regimens followed by high-dose therapy with Stem cell transplantation in mantle cell lymphoma: an update of a prospective study
- Adult Burkitt’s and Burkitt-like non-Hodgkin’s lymphoma–outcome for patients treated with high-dose therapy and autologous Stem–cell transplantation in first remission …
- Hematopoietic Stem cell gene therapy: selecting only the best
- … reconstitution after autologous hematopoietic Stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications
- … followed by high-dose therapy with Stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell …
- High-dose therapy and autologous Stem–cell support for chemosensitive transformed low-grade follicular non-Hodgkin’s lymphoma: a case-matched study from the …
- Hormonal replacement therapy after Stem cell transplantation
- High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic Stem cell transplantation for relapsed follicular non-Hodgkin …
- Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and Stem cell rescue
- Myeloablative therapy with blood Stem cell transplantation is effective in mantle cell lymphoma.
- Temporary corneal Stem cell dysfunction after radiation therapy.
- Early autologous Stem–cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin’s lymphoma: an Italian …
- Therapeutic Effects of Massage therapy and Healing Touch on Caregivers of Patients Undergoing Autologous Hematopoietic Stem cell Transplant.
- Progress toward vector design for hematopoietic Stem cell gene therapy
- Embryonic and adult Stem cells as a source for cell therapy in Parkinson’s disease
- High-dose therapy followed by autologous hematopoietic Stem–cell infusion for patients with multiple myeloma.
- … relapsed or refractory Hodgkin’s disease treated with high-dose chemotherapy and Stem cell rescue at the time of maximal response to conventional salvage therapy …
- cell-replacement therapy with Stem cells in neurodegenerative diseases
- Retroviral Stem cell gene therapy
- Mesenchymal Stem cells: cell biology and potential use in therapy
- High-dose therapy followed by autologous peripheral-blood Stem–cell transplantation for patients with Hodgkin’s disease and non-Hodgkin’s lymphoma using …
- Human pancreatic Stem cell and diabetes cell therapy
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin’s lymphoma: an evidence …
- Current antiviral strategies for controlling cytomegalovirus in hematopoietic Stem cell transplant recipients: prevention and therapy
- Risk to the coronary arteries of intracoronary Stem cell infusion and G-CSF cytokine therapy.
- High-dose therapy and autologous Stem cell rescue for patients with Hodgkin’s disease in first relapse after chemotherapy: results from the EBMT
- Therapeutic cloning and Stem cell therapy
- Stem cells in cardiovascular disease: from cell biology to clinical therapy
- … emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with Stem cell …
- … photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic Stem cell …
- Haematopoietic Stem cell transplantation and gene therapy in the fetus: ready for clinical use?
- High-dose therapy plus autologous hematopoietic Stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV …
- … -emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic Stem cell transplantation: a single …
- Stem cell transplantation therapy: controversy over ethical issues and clinical relevance.
- Adult Stem cell technology-prospects for cell based therapy in regenerative medicine
- High-dose chemotherapy followed by autologous Stem cell transplantation as first-line therapy in aggressive non-Hodgkin’s lymphoma: a meta-analysis
- Second malignancy following high-dose therapy and autologous Stem cell transplantation: incidence and risk factor analysis
- Epstein-Barr virus (EBV) reactivation in allogeneic Stem–cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy
- Myeloablative radiochemotherapy followed by autologous peripheral blood Stem cell transplantation as first-line therapy in peripheral T-cell lymphomas: first results of …
- High-dose therapy with autologous Stem–cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the …
- High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow Stem cell transplant recipients
- Hematopoietic Stem cell gene therapy: progress toward therapeutic targets
- Stem cell biology and gene therapy
- High-dose therapy with autologous Stem cell rescue for pediatric sarcomas
- … lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic Stem cell transplantation for severe …
- Parainfluenza virus type 3 infections in hematopoetic Stem cell transplant recipients: response to ribavirin therapy
- 10 Current status of Stem cell therapy and prospects for gene therapy for the disorders of globin synthesis
- Hematopoietic Stem cell gene therapy
- Stem cell Gene therapy for the β‐Chain Hemoglobinopathies: Problems and Progressa
- Hematopoietic Stem cell depletion by restorative growth factor regimens during repeated high-dose cyclophosphamide therapy [see comments]
- High-dose consolidation therapy with autologous Stem cell rescue in stage IV breast cancer.
- High-dose therapy/autologous Stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission
- Stem cell therapy and research
- High-dose immunoablative therapy with hematopoietic Stem cell support in the treatment of severe autoimmune disease: current status and future direction
- High-dose chemotherapy (HDC) and autologous hematopoietic Stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma
- High-dose consolidation therapy with autologous Stem–cell rescue in stage IV breast cancer: follow-up report.
- Toward Epidermal Stem cell-Mediated ex Vivo Gene therapy of Junctional Epidermolysis Bullosa
- Mesenchymal Stem cells from the bone marrow stroma: basic biology and potential for cell therapy
- High-dose multimodality therapy with autologous Stem–cell support for stage IIIB breast carcinoma.
- … load in plasma allows for fast and accurate prediction of response to therapy of Epstein–Barr virus‐associated lymphoproliferative disease after allogeneic Stem cell …
- Single agent dexamethasone for pre-Stem cell transplant induction therapy for multiple myeloma
- Efficacy of high-dose therapy and autologous hematopoietic Stem cell transplantation for non-Hodgkin’s lymphoma in adults 60 years of age and older
- Arsenic Trioxide (Trisenox®) therapy for Acute Promyelocytic Leukemia in the Setting of Hematopoietic Stem cell Transplantation
- Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic Stem cell transplantation: a pilot study
- Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and Stem cell …
- … high-dose cyclophosphamide without Stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease
- High dose therapy and autologous Stem cell transplantation for human immunodeficiency virus‐associated non‐Hodgkin lymphoma in the era of highly active …
- Autologous peripheral blood Stem cell transplantation after high dose therapy in patients with advanced lymphomas.
- Hematopoietic Stem cell gene therapy: a current overview.
- Muscle-derived Stem cells: characterization and potential for cell-mediated therapy
- Immunotherapy with rituximab following high-dose therapy and autologous Stem–cell transplantation for mantle cell lymphoma
- Improved cerebrovascular patency following therapy in patients with sickle cell disease: initial results in 4 patients who received HLA‐identical hematopoietic Stem cell …
- … with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood Stem cell transplantation in elderly …
- therapy with imatinib mesylate (Glivec) preceding allogeneic Stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute …
- High-activity samarium-153-EDTMP therapy followed by autologous peripheral blood Stem cell support in unresectable osteosarcoma
- Benefit of aggressive multimodality therapy with autologous Stem cell support for intra-abdominal desmoplastic small round cell tumor
- Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic Stem cell transplantation
- Stem–cell therapy for myocardial diseases
- Cytokine production during myeloablative and reduced intensity therapy before allogeneic Stem cell transplantation
- High risk of therapy-related leukemia after BEAM chemotherapy and autologous Stem cell transplantation for previously treated lymphomas is mainly related to primary …
- Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic Stem cell transplantation
- Results of high-dose therapy and autologous bone marrow/Stem cell transplantation during remission in poor-risk intermediate-and high-grade lymphoma …
- Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic Stem cell …
- High-dose therapy in lymphomas: a review of the current status of allogeneic and autologous Stem cell transplantation in Hodgkin’s disease and non-Hodgkin’s …
- Melphalan-associated pulmonary toxicity following high-dose therapy with autologous hematopoietic Stem cell transplantation
- Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous Stem cell transplant
- Stem cell gene therapy, position effects and chromatin insulators
- Role for high-dose therapy with autologous hematopoietic Stem cell support in Waldenstrom’s macroglobulinemia
- The hematopoietic Stem cell therapy for exploration of deep space
- … mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic Stem cell transplantation: a prospective …
- … determinant (CD) 34+ cell dose on the cost and consequences of peripheral blood Stem cell transplantation for non-Hodgkin’s lymphoma patients in front-line therapy
- Sequential high-dose therapy and autologous Stem cell transplantation for treatment of mantle cell lymphoma
- High-dose therapy and autologous Stem cell transplant does not result in long-term disease-free survival in patients with recurrent chemotherapy-sensitive …
- Adult mesenchymal Stem cells: characterization, differentiation, and application in cell and gene therapy
- Evaluation of the risk of therapy-related MDS/AML after autologous Stem cell transplantation
- Intensification of therapy using hematopoietic Stem‐cell support for high‐risk neuroblastoma
- Strategies for hematopoietic Stem cell gene therapy: insights from computer simulation studies
- A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic Stem cell transplantation
- Stem cell defects after cytoreductive therapy in man.
- … with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or Stem cell rescue therapy
- Myeloma cell contamination of peripheral blood Stem cell grafts in patients with multiple myeloma treated by high-dose therapy.
- Embryonic Stem cell grafting: the therapy of the future?
- Transabdominal first trimester embryofetoscopy as a potential approach to early in utero Stem cell transplantation and gene therapy
- Single center experience of a new intensive induction therapy for Ewing’s family of tumors: feasibility, toxicity, and Stem cell mobilization properties
- Pre-emptive therapy with rituximab for prevention of Epstein–Barr virus-associated lymphoproliferative disease after hematopoietic Stem cell transplantation
- High-dose therapy and autologous Stem cell transplantation in relapsing cutaneous lymphoma
- Peripheral blood Stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study
- … (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin’s lymphoma after high-dose therapy and autologous peripheral Stem cell …
- Where next with Stem–cell-supported high-dose therapy for breast cancer?
- Clonotypic CD20+ and CD19+ B cells in peripheral blood of patients with multiple myeloma post high‐dose therapy and peripheral blood Stem cell transplantation
- Lymphoid development and function in X-linked severe combined immunodeficiency mice after Stem cell gene therapy
- Consolidation therapy with autologous Stem cell transplantation in plasma cell leukemia after VAD, high-dose cyclophosphamide and EDAP courses: a report of three …
- Analysis of feasibility of myeloablative therapy and autologous peripheral Stem cell (PBSC) transplantation in the elderly: an interim report
- Embryonic Stem cells in vitro-prospects for cell and developmental biology, embryotoxicology and cell therapy
- Peripheral blood Stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood …
- An update on the role of high-dose therapy with autologous or allogeneic Stem cell transplantation in mantle cell lymphoma
- Hematopoietic Stem cell transplantation for cancer therapy
- Hematopoietic Stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid …
- Hematopoietic Stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selection
- Superiority of double over single autologous Stem cell transplantation as first-line therapy for multiple myeloma.
- … (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic Stem cell …
- Twelve years experience with high-dose therapy and autologous Stem cell transplantation for high-risk Hodgkin’s disease patients in first remission after MOPP/ABVD …
- Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood Stem cell transplantation
- The role of autologous Stem cell reconstitution in intensive therapy for resistant neoplasms
- Nonmyeloablative therapy and allogeneic hematopoietic Stem cell transplantation
- Decitabine with allogeneic peripheral blood Stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study
- Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous Stem cell transplantation for salvage therapy in B-NHL
- The place of high-dose therapy with haemopoietic Stem cell transplantation in relapsed and refractory Hodgkin’s disease
- siRNAs, ribozymes and RNA decoys in modeling Stem cell-based gene therapy for HIV/AIDS.
- Clinically‐based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic Stem cell …
- Embryonic Stem cell research and therapy: the need for a common European legal framework
- … high-dose chemotherapy with granulocyte colony-stimulating factor and autologous Stem–cell transplantation support as first-line therapy in high-risk diffuse large-cell …
- Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood Stem cell transplantation …
- Marginal benefit/disadvantage of granulocyte colony-stimulating factor therapy after autologous blood Stem cell transplantation in children: results of a prospective …
- Nutritional support of the patient receiving high-dose therapy with hematopoietic Stem cell support
- … Stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with α/β hepatosplenic T-cell …
- … boydii) brain abscess during therapy for invasive pulmonary aspergillosis following high‐risk allogeneic hematopoietic Stem cell transplantation. Scedosporiasis and …
- Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic Stem cell transplantation
- … long‐term hematologic recovery despite a marked quantitative defect in the Stem cell compartment of patients with aplastic anemia after immunosuppressive therapy
- Lack of emergence of cytomegalovirus UL97 mutations conferring ganciclovir (GCV) resistance following preemptive GCV therapy in allogeneic Stem cell transplant …
- Potential use of human Stem cell factor as adjunctive therapy for human immunodeficiency virus-related cytopenias
- Effectiveness of high‐dose MCNU therapy and hematopoietic Stem cell autografts treatment of childhood acute leukemia/lymphoma with high‐risk features
- Interleukin-2 therapy after bone marrow or Stem cell transplantation for hematologic malignancies.
- Cytokines: value-added products in hematopoietic Stem cell gene therapy
- … of Multiple Myeloma and Breast Cancer cells by TH9402‐mediated Photodynamic therapy: Implication for Clinical Ex Vivo Purging of Autologous Stem cell …
- Antimicrobial therapy of febrile complications after high-dose chemo-/radiotherapy and autologous hematopoietic Stem cell transplantation
- Autologous Stem cell transplantation for AL amyloidosis: a standard therapy?
- A prospective randomized trial of granulocyte colony-stimulating factor therapy after autologous blood Stem cell transplantation in adults
- Hematopoietic Stem cell gene therapy: towards clinically significant gene transfer efficiency.
- Minimal residual disease–based role of imatinib as a first-line interim therapy prior to allogeneic Stem cell transplantation in Philadelphia chromosome–positive acute …
- Search for a cure for idiopathic pulmonary fibrosis: is Stem cell therapy a light at the end of a long tunnel?
- Stem cell Transplantationfor Leukemias Following Myelodysplastic Syndromesor Secondaryto Cytotoxic therapy
- Hematopoietic Stem cell–based gene therapy for acquired immunodeficiency syndrome: efficient transduction and expression of RevM10 in myeloid cells in vivo and …
- Stem cell therapy (Aastrom Biosciences Inc).
- High-dose chemotherapy with Stem cell rescue as initial therapy for anaplastic oligodendroglioma
- Directed mobilization of endogenous neural progenitor cells: the intersection of Stem cell biology and gene therapy.
- High‐dose intravenous methotrexate followed by autologous Stem cell transplantation as a potentially effective therapy for neurolymphomatosis
- 6The role of haematopoietic Stem cell-supported myeloablative therapy for the management of multiple myeloma
- Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood Stem cell transplantation
- Early intensive therapy with autologous Stem cell transplantation in advanced Hodgkin’s disease: retrospective analysis of 158 cases from the French registry
- Ultrasound-guided Stem cell sampling from the early ovine fetus for prenatal ex vivo gene therapy
- Hematopoietic Stem cell therapy for multiple sclerosis
- The remission status before and the PCR status after high-dose therapy with peripheral blood Stem cell support are prognostic factors for relapse-free survival in …
- Hematopoietic Stem cell gene replacement therapy
- … by non-myeloablative allogeneic Stem cell transplantation in multiple myeloma: results of a pilot study as salvage therapy after autologous transplantation
- Peripheral blood Stem cell transplantation after high-dose therapy in patients with malignant lymphoma: a retrospective comparison with autologous bone marrow …
- Stem cell therapy for intervertebral disc diseases in vitro and in vivo feasibility study
- The leukemogenic risk of integrating retroviral vectors in hematopoietic Stem cell gene therapy applications.
- Functional organization of the hematopoietic Stem cell compartment: implications for cancer and its therapy.
- The importance of CD34+/CD33− cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood Stem cell rescue
- … suppression and autologous hematopoietic Stem cell transplantation in severe Crohn’s disease refractory to immunosuppressive and immunomodulator therapy
- Micro-injection-mediated hematopoietic Stem cell gene therapy.
- Early allogeneic blood Stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid …
- Fetal immune suppression as adjunctive therapy for in utero hematopoietic Stem cell transplantation in nonhuman primates
- Development of a modified selective amplifier gene for hematopoietic Stem cell gene therapy
- Embryonic Stem cells: a promising tool for cell replacement therapy
- Clinical benefits of granulocyte colony-stimulating factor therapy after hematopoietic Stem cell transplant in children: results of a prospective randomized trial
- Value of autologous Stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS …
- Late infectious complications after high-dose therapy and autologous blood Stem cell transplantation
- Stem cell gene therapy: a breakthrough combination magnified by therapeutic Stem cell homing
- Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous Stem cell transplantation
- Peripheral blood Stem cell mobilization following CHOP plus rituximab therapy combined with G-CSF in patients with B-cell non-Hodgkin’s lymphoma
- Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis after Stem cell transplantation: effective monitoring of CMV infection by quantitative …
- Highly active antiretroviral therapy corrects hematopoiesis in HIV-1 infected patients: interest for peripheral blood Stem cell-based gene therapy
- Feasibility of multidrug resistance (MDR-1) gene transfer in patients undergoing high-dose therapy and peripheral blood Stem cell transplantation for lymphoma
- Platelet flow cytometric findings in patients undergoing conditioning therapy for allogeneic hematopoietic Stem cell transplantation
- Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood Stem cell transplant when started soon after engraftment
- Bone marrow Stem cell gene therapy of arylsulfatase A-deficient mice, using an arylsulfatase A mutant that is hypersecreted from retrovirally transduced donor-type …
- Front-line high-dose therapy with autologous Stem cell transplantation for high risk Hodgkin’s disease: comparison with combined-modality therapy
- Anti-CD20 monoclonal antibody therapy for autoimmune hemolytic anemia following T cell-depleted, haplo-identical Stem cell transplantation
- Plasticity of skeletal muscle differentiation generating Stem cell-like phenotype: Possible application to cell therapy for muscular diseases
- The Hematopoietic Stem cell therapy for Exploration of Space
- Selective expansion of transduced cells for hematopoietic Stem cell gene therapy
- Progress towards hematopoietic Stem cell gene therapy.
- Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic Stem cell …
- When to harvest peripheral-blood Stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in …
- Globin gene transfer for the treatment of severe hemoglobinopathies: a paradigm for Stem cell‐based gene therapy
- Autologous blood Stem cell transplantation as therapy for autoimmune diseases
- High‐dose therapy/Stem cell support: Comparison of mice and humans
- High‐dose therapy with Stem cell rescue for pediatric solid tumors: Rationale and results
- Transfusion therapy in the patient undergoing hematopoietic Stem cell transplantation
- Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood Stem cell transplantation
- Intra-muscular vidarabine therapy for polyomavirus-associated hemorrhagic cystitis following allogeneic hemopoietic Stem cell transplantation
- Multivalent anti-CCR5 ribozymes for Stem cell-based HIV type 1 gene therapy
- Renal dysfunction during high-dose cisplatin therapy and autologous hematopoietic Stem cell transplantation: effect of aminoglycoside therapy
- High-dose therapy with Stem–cell transplantation in the malignant lymphomas.
- … Stem and progenitor cells from acid sphingomyelinase-deficient mice: implications for Niemann-Pick disease gene therapy and the development of improved Stem cell …
- Treatment of mantle-cell lymphomas with the VAD+/− chiorambucil regimen with or without subsequent high-dose therapy and peripheral blood Stem–cell …
- … Stem cell transplantation as post-remission therapy in adult acute myelogenous leukemia: does platelet contamination of peripheral blood mobilized Stem cell grafts …
- High-dose therapy and autologous peripheral Stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone …
- … of the tumor load predicts progressive disease in patients with multiple myeloma after high-dose therapy with autologous peripheral blood Stem cell …
- Technology evaluation: Stem–cell therapy, Aastrom Biosciences Inc.
- … colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic Stem cell transplantation for lymphoid …
- The present role of bone marrow and Stem cell transplantation in the therapy of children with acute leukemia.
- Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H. 82 with autologous Stem cell support and cyclosporin A
- Stem cell transplantation and gene therapy for HIV-related lymphomas
- High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood Stem cell support in the adjuvant therapy of high-risk breast cancer: a practical …
- High-dose therapy and Stem cell transplantation in follicular lymphoma
- Allogeneic hematopoietic Stem–cell transplantation: the next generation of therapy for metastatic renal cell cancer
- … for cytomegalovirus disease in patients receiving polymerase chain reaction–based preemptive antiviral therapy after allogeneic Stem cell transplantation depends on …
- Autologous peripheral blood Stem cell transplantation (PBSCT) mobilized with G-CSF in AML in first complete remission. Role of intensification therapy in outcome
- Retroviral vector design studies toward hematopoietic Stem cell gene therapy for mucopolysaccharidosis type I
- Adult Stem cells and their importance in cell therapy.
- A novel sub-population of bone marrow–derived myocardial Stem cells: potential autologous cell therapy in myocardial infarction
- Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and Stem cell transplant
- Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic Stem cell transplantation
- High dose therapy and autologous Stem cell transplantation in follicular non-Hodgkin’s lymphoma
- Multidisciplinary therapy including high-dose chemotherapy followed by peripheral blood Stem cell transplantation for invasive thymoma
- High dose therapy and autologous hematopoietic Stem cell transplantation in poor risk solid tumors of childhood.
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the treatment of diffuse large cell B-cell non-Hodgkin’s lymphoma
- Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and Stem cell rescue. A feasibility study
- … carboplatin and interleukin-2 (IL-2) activated autologous Stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma–a …
- Filgrastim‐induced Stem cell mobilization in chronic myeloid leukaemia patients during imatinib therapy: safety, feasibility and evidence for an efficient in vivo purging
- The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and Stem cell gene therapy for AIDS
- Intensive therapy and autologous Stem cell transplantation for Hodgkin’s disease in first relapse after combination chemotherapy
- Stem cell-based gene therapy
- Stem–cell depletion and grid therapy
- Adult Stem cell therapy: Imagining Futures in cell Biology
- Long-term survival in primary plasma cell leukemia after therapy with VAD, autologous blood Stem cell transplantation and interferon-alpha
- … of autologous Stem cell transplantation in patients with multiple myeloma who received dexamethasone-based nonmyelosuppressive induction therapy
- Consolidation therapy with autologous blood Stem cell transplantation in a patient with primary plasma cell leukaemia
- … therapy for remission in myeloma with Intron A following high-dose melphalan and either an autologous bone marrow transplantation or peripheral Stem cell rescue.
- Intermediate‐dose melphalan (IDM) combined with G‐CSF (filgrastim) is an effective and safe induction therapy for autologous Stem cell transplantation in multiple …
- … therapy for Hodgkin’s disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous Stem …
- Stem cell therapy: medical advance or moral challenge?
- Experience with liposomal Amphotericin‐B in 60 patients undergoing high‐dose therapy and bone marrow or peripheral blood Stem cell transplantation
- In utero hematopoietic Stem cell transplantation: a caprine model for prenatal therapy in inherited metabolic diseases
- … non-Hodgkin’s lymphoma after high-dose therapy and autologous peripheral Stem–cell transplantation: changing the natural history with monoclonal antibody therapy
- Future cure of hearing disorders? Gene therapy and Stem cell implantation are possible new therapeutic alternatives
- Thiotepa and cyclophosphamide with Stem cell rescue for consolidation therapy for children with high-risk neuroblastoma: a phase I/II study of the Pediatric Blood and …
- High‐dose therapy and autologous blood Stem cell transplantation in multiple myeloma: Preliminary results of a randomized trial involving 167 patients
- Interferon-α therapy following autologous peripheral blood Stem cell transplantation for adult T cell leukemia/lymphoma
- Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, and topotecan with peripheral-blood Stem–cell support as front-line therapy
- Hematopoietic Stem cell gene therapy for Niemann–Pick disease and other lysosomal storage diseases
- Neural Stem cells are uniquely suited for cell replacement and gene therapy in the CNS
- Stem cell component therapy: supplementation of unmanipulated marrow with CD34 enriched peripheral blood Stem cells
- Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood Stem cell support is an effective adjuvant treatment for high-risk primary breast …
- Donor chimerism and Stem cell function in a murine congenic transplantation model after low-dose radiation conditioning: effects of a retroviral-mediated gene transfer …
- Stem cell therapy for severe autoimmune diseases
- … use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic Stem cell transplantation as consolidation therapy for high-risk …
- Retroviral transduction of T lymphocytes for suicide gene therapy in allogeneic Stem cell transplantation
- … survival of children with advanced neuroblastoma treated by intensified therapy including myeloablative chemotherapy with Stem cell transplantation: a retrospective …
- therapy-related myelodysplastic syndrome after autologous Stem cell transplantation for breast cancer
- … significance of the detection of tumour cells in peripheral blood Stem cell collections in stage II and III breast cancer patients treated with high-dose therapy
- Male germ line Stem cells: from cell biology to cell therapy?
- High dose therapy with autologous Stem cell transplantation for solitary bone plasmacytoma complicated by local relapse or isolated distant recurrence
- Cytomegalovirus following Stem cell transplantation: from pharmacologic to immunologic therapy
- High-dose therapy followed by Stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin’s lymphoma
- High-dose therapy and autologous Stem cell rescue for poor risk and refractory lymphoma: a single centre experience of 123 patients.
- The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic Stem cell transplantation for patients with chronic myelogenous …
- Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood Stem cell transplantation
- … of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood Stem cell …
- High-dose therapy with Stem cell support in solid tumors
- cell sources and support programs for Stem cell research and cell-based therapy in the USA
- Immune ablation and Stem–cell therapy in autoimmune disease Introduction
- Current status in intrauterine fetal Stem cell therapy
- … exposure to Merocyanine 540-mediated photodynamic therapy and Edelfosine: implications for the ex vivo purging of autologous haematopoietic Stem cell …
- Allogeneic Stem cell–Derived “Repair Unit” therapy and the Barriers to Clinical Deployment
- Autologous Stem cell therapy for syStemic vasculitis
- Diabetes therapy boosts Stem–cell campaign
- Once weekly recombinant human erythropoietin therapy is very efficient after allogeneic peripheral blood Stem cell transplantation when started soon after …
- A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood Stem cell transplantation as initial therapy for patients with high-risk non …
- Stem–cell gene therapy moves toward approval: an NIH advisory committee gives the nod to a new strategy for genetic therapy based on a rare type of blood cell
- Dog leukocyte antigen-haploidentical Stem cell allografts after anti-CD44 therapy and reduced-intensity conditioning in a preclinical canine model
- The case for and against high-dose therapy with Stem cell rescue for early poor prognosis Hodgkin’s disease in first remission
- Lamivudine therapy for a hepatitis B surface antigen (HBsAg)-positive leukemia patient receiving myeloablative chemotherapy and autologous Stem cell …
- Neural Stem cells–a versatile tool for cell replacement and gene therapy in the central nervous syStem: Section Editor: Roderick R McInnes e‐mail: mcinnes@ sickkids …
- Cidofovir for cytomegalovirus-preemptive therapy in Stem cell transplant recipients
- Autologous Stem cell Transplantation as First Line therapy in Peripheral T cell Lymphomas. Update of a Prospective Multicenter Study.
- 1432: The Effect of Neural Embryonic Stem cell therapy in a Rat Model of Cavernous Nerve Injury
- In vitro T lymphopoiesis: a model syStem for Stem cell gene therapy for AIDS
- Immune therapy for EBV infections after hemopoietic Stem–cell transplant
- Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous Stem cell support
- High‐dose therapy with peripheral blood Stem cell transplantation results in a significant reduction of the haemopoietic progenitor cell compartment
- … ‐dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood Stem cell …
- Autologous Stem cell transplantation as adjuvant treatment vs no further therapy for poor-risk Hodgkin’s disease in first complete remission after MOPP/ABVD
- Autologous blood Stem cell transplantation for acute myeloblastic leukemia in first complete remission. Intensification therapy before transplantation does not prolong …
- High-dose therapy with peripheral blood Stem cell transplantation for patients with relapsed or refractory Hodgkin’s disease: long-term outcome and prognostic factors
- … antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through Stem cell factor/granulocyte-macrophage …
- A human pluripotent Stem cell in the blood of adults: towards a new cellular therapy for tissue repair
- PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous Stem cell transplantation is a prognostic factor for event-free survival …
- … /nonlymphoid antigen+ acute leukemias: immunologic and karyotypic monitoring during therapy and at relapse suggests the transformation of a bipotential Stem cell.
- High dose therapy followed by autologous peripheral blood Stem cell transplantation as a first line treatment for multiple myeloma: a Korean Multicenter Study
- Neural Stem cell therapy
- Circulating hematopoietic Stem cell populations in human fetuses: implications for fetal gene therapy and alterations with in utero red cell transfusion
- … -associated pulmonary alveolar proteinosis as two hereditary diseases of childhood which are potentially curable by Stem cell gene therapy but require different …
- … of interferon tolerance after autologous bone marrow or peripheral blood Stem cell transplants for myeloma patients who have responded to induction therapy
- … suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN, high-dose chemotherapy and autologous Stem cell …
- Tandem high-dose therapy followed by autologous Stem–cell transplantation for refractory or relapsed high grade non-Hodgkin’s lymphoma with poor prognosis …
- Efficacy and toxicity of sequential high-dose therapy with peripheral blood Stem cell support in patients with high-risk breast cancer.
- Hematopoietic Stem cell gene therapy: progress and prospects
- Purging of contaminating breast cancer cells from hematopoietic Stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation
- … cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood Stem cell harvests and bone marrow after therapy
- Embryonic Stem cell therapy: Progress and Perspectives
- High-dose combined alkylating agent therapy with autologous Stem cell support and chest radiotherapy for limited small-cell lung cancer
- Allogenic Stem cell transplantation as salvage therapy for patients relapsing after autologous transplantation: experience from a single institution
- Development of gene therapy for hematopoietic Stem cell using viral vectors
- Stem cell therapy: prospects and
- Toxic megacolon: a life-threatening complication of high-dose therapy and autologous Stem cell transplantation among patients with AL amyloidosis
- Blood Stem cell transplantation and gene therapy of cancer
- MESENCHYMAL Stem cell therapy IN GROWTH PLATE CARTILAGE INJURY
- Empiric antimicrobial therapy of febrile neutropenic patients undergoing haematopoietic Stem cell transplantation
- Repetitive low-dose radiation therapy for acute Stem–cell leukemia
- Modeling human hematopoietic Stem cell gene therapy in nonhuman primates.
- The role of high-dose therapy with hematopoietic Stem cell rescue in low-grade non-Hodgkin’s lymphoma
- Intensified daunorubicin in induction therapy and autologous peripheral blood Stem cell transplantation in postremission therapy (Double-7 protocol) for adult acute …
- Mobilization of peripheral blood Stem cells (PBSCs) after etoposide, adriamycin and cisplatin therapy, and a multimodal cell therapy approach with PBSCs in …
- High-dose chemotherapy and autologous Stem cell support followed by post-transplant doxorubicin and taxol as initial therapy for metastatic breast cancer …
- Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous Stem cell support in patients …
- Survival after high-dose therapy with autologous Stem cell support
- Stem–cell researchers offer possible therapy for diabetes
- Hematopoietic Stem cell gene therapy for inherited bone marrow disorders: past accomplishments and continued challenges
- ESHAP+/− Rituximab as Salvage therapy for Relapsed Lymphoma Prior to Stem cell Transplant: Single Institution Experience.
- Stem cell (CFU-S) inhibitory peptides: Biological properties and application of pEEDCK as hemoprotector in cytostatic tumor therapy
- High-dose therapy and autologous Stem cell transplantation for high-risk Hodgkin’s lymphoma: a single center experience
- Outcome after Second Autologous Stem cell Transplantation as Salvage therapy in Patients with Relapsed Multiple Myeloma.
- Complications after high dose therapy and autologous Stem cell transplantation. Retrospective study of an unselected patient sample
- Feasibility of using autologous transplantation to evaluate hematopoietic Stem cell-based gene therapy strategies in transgenic mouse models of human …
- … in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood Stem cell …
- Pulmonary infiltrates after cytokine therapy for Stem cell transplantation: massive deposition of eosinophil major basic protein detected by immunohistochemistry
- Hematopoietic Stem cell therapy.
- THE ETHICS OF Stem cell therapy
- High-dose therapy with autologous bone marrow Stem cell support in primary and metastatic human breast cancer
- Hematopoietic Stem cell autografts in support of myeloablative therapy for multiple myeloma
- The third conference on hematopoietic Stem cell gene therapy: biology and technology
- Survival Following Etanercept therapy for the Treatment of Idiopathic Pneumonia Syndrome Post Allogeneic Stem cell Transplantation.
- Excellent disease eradication by myeloablative therapy and Stem–cell transplantation in patients with acute myelogenous leukemia
- Phase I/II trials of autologous peripheral blood Stem cell transplantation in autoimmune diseases resistant to conventional therapy: preliminary results from the …
- NOVEL CLINICAL CONCEPTS ON Stem cell therapy: 336
- Monoclonal antibody therapy with autologous peripheral blood Stem cell transplantation for non-Hodgkin’s lymphoma
- Lamivudine therapy for acute hepatitis B infection following peripheral blood Stem cell transplantation
- The addition of topotecan to carboplatin and paclitaxel as first-line therapy for advanced ovarian cancer; is it possible only with peripheral blood Stem cell support?
- … high dose therapy and autologous Stem cell transplantation versus conventional therapy for patients with advanced Hodgkin’s disease responding to first line therapy
- Results of a Multi-Center Randomized Phase II Trial of Thalidomide and Prednisone Maintenance therapy for Multiple Myeloma Following Autologous Stem cell …
- Mesenchymal and nonhematopoietic Stem–cell therapy
- Neurosurgical Stem cell therapy
- A Stem cell therapy for stroke
- Embryonic Stem cell lines for regenerative therapy and pharmaceutical research
- Effect of prior therapy and bone marrow metastases on progenitor cell content of blood Stem cell harvests in breast cancer patients
- … by campath mab t cell depleted Stem cell allograftP14. Stem cell treatment in inflammatory myopathies: proposals for patient selectionP15. Autologous Stem cell …
- ALLOGENEIC Stem cell therapy FOR JOINT DISEASE
- … Foundations. Note: A. Hultquist is presently at the Department of Stem cell Biology, Strategic Center for Stem cell Research and Gene therapy, Lund University, S …
- High-dose chemotherapy and autologous Stem cell support followed by posttransplantation doxorubicin as initial therapy for metastatic breast cancer.
- Early infectious complications after high-dose therapy and autologous blood Stem cell transplantation
- High dose therapy and autologous hemopoietic Stem